Following on the release of the first comprehensive analysis of the global impact of AMR, published in The Lancet in late January 2022, the GCOA paper aims to demystify the terminology and clearly lay out the global threat posed by rising drug resistance and accompanying lack of effective new drugs in the development pipeline. The paper…

GCOA’s Digital Health Working Group (DHWG) brings together members from across sectors to share ideas, initiatives, best practices, and policies related to digital health technologies. The goal of the DHWG is to  advance the application of digital technologies to support healthier aging for more people around the globe. Watch the video below to learn more…

In May 2021, the Global Coalition on Aging (GCOA) and the Health and Global Policy Institute (HGPI) hosted a second joint roundtable on the challenges of antimicrobial resistance (AMR) in super-aging Japan. The roundtable brought together Japanese and global experts in aging and infectious disease, examining in particular the coupled crises of antimicrobial resistance (AMR) and…

In May 2021, GCOA and the Health and Global Policy Institute (HGPI) hosted a private roundtable of Japanese and global experts and decision makers to examine the connection between innovation for healthy aging and economic growth in super-aging Japan and other rapidly aging societies across the OECD. The roundtable and subsequent report, released in October…

This report summarizes key takeaways from our October 2020 virtual roundtable on health innovation and economic growth in Japan. The report highlights the importance of health innovation in Japan and in ageing societies around the world. GCOA and the Health and Global Policy Institute (HGPI) co-organized the roundtable, which was sponsored by Pfizer Japan. The roundtable was…